论文部分内容阅读
对１０５例鼻咽癌较大颈淋巴结转移患者进行随机对照研究，３５例采用神龙液加热疗并放射治疗（Ａ组），３５例采用热疗加放射治疗（Ｂ组），３５例行单纯放射治疗（Ｃ组）。３组患者治疗前临床情况均相似，治疗结束时，颈淋巴结消退率Ａ组为６８．５７％，Ｂ组为６０．００％，Ｃ组为４２．８６％，以Ａ组为最高。经统计学处理，Ａ组与Ｃ组比较，有显著性差异（Ｐ＜０．０５）；Ｂ组分别与Ａ组、Ｃ组比较，均无显著性差异（Ｐ均＞０．０５）。研究提示中西医结合治疗鼻咽癌较大颈淋巴结转移是可取的，神龙液对鼻咽癌的热疗、放疗有增效减毒作用，不增加血行转移。
A total of 105 patients with NPC with large cervical lymph node metastasis were randomized controlled study. 35 cases were treated with Shenlong fluid with radiotherapy (group A), 35 cases with hyperthermia plus radiotherapy (group B), 35 cases with simple Radiotherapy (C group). The clinical status of the three groups before treatment was similar. At the end of treatment, the regression rate of cervical lymph node was 68.57% in group A, 60.00% in group B, 42.86% in group C, and the highest in group A. There was significant difference between group A and group C (P <0.05). There was no significant difference between group A and group C (all P> 0.05). Research suggests that the combination of traditional Chinese and Western medicine treatment of nasopharyngeal large cervical lymph node metastasis is desirable, Shenlong fluid nasopharyngeal cancer hyperthermia, radiotherapy have synergistic attenuated effect, does not increase the hematogenous metastasis.